Hidradenitis Suppurativa clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Imsidolimab (ANB019) in the Treatment of Subjects With Hidradenitis Suppurativa
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18-75
Efficacy and Safety of Imsidolimab (ANB019) in Subjects with Hidradenitis Suppurativa
Sacramento, California and other locations
Last updated: